BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//IBSAL - ECPv6.17.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:IBSAL
X-ORIGINAL-URL:https://ibsal.es/en/
X-WR-CALDESC:Events for IBSAL
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260210
DTEND;VALUE=DATE:20260916
DTSTAMP:20260225T064245Z
CREATED:20260225T064245Z
LAST-MODIFIED:20260225T064245Z
UID:25034-1770681600-1789516799@ibsal.es
SUMMARY:Horizon Europe. Cancer Mission 2026 and 2027
DESCRIPTION:Features\nThe work program for the  Cancer Missions under Horizon Europe for 2026 and 2027. \nThese are single-phase calls for proposals\, aimed at international multidisciplinary consortia\, which must submit a proposal in accordance with the specifications for each topic. \nAdmission requirements\, eligibility criteria\, and the necessary documents are described in the General Annexes. \n  \nThese are the topics included in the Cancer Mission’s new Work Program for the year 2026: \nThese topics are single-phase: they begin on February 10\, 2026\, and end on September 15\, 2026. \nHORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research \nHORIZON-MISS-2026-02-CANCER-02: Microbiome for Early Cancer Prediction Before the Onset of Disease \n\nHORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimize immunotherapy interventions for patients with refractory cancers \nHORIZON-MISS-2026-02-CANCER-04: Earlier and More Precise Palliative Care \nHORIZON-MISS-2026-02-CANCER-05: Improving the mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC) \nHORIZON-MISS-2026-02-CANCER-06: Development of a research capacity-building program on cancer with and for Ukraine (csa) \nHORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of Older Cancer Patients \n\nA very interesting topic in the “Soil Deal for Europe” section\, which opens on February 4\, 2026\, and closes on September 23\, 2026: \nHORIZON-MISS-2026-05-SOIL-02: Antimicrobial Resistance and Antibiotic Biosynthesis in Soils: Developing Key Insights and Countermeasures Using a One-Health Approach \n  \nThese are the topics included in the Cancer Mission’s new Work Program for the year 2027: \nThese topics are single-phase: they begin on February 10\, 2027\, and end on September 21\, 2027. \nHORIZON-MISS-2027-02-CANCER-01: Leveraging functional genomics to identify novel targets for cancer treatment \nHORIZON-MISS-2027-02-CANCER-02: Clinical research conducted by Comprehensive Cancer Infrastructures for the benefit of patients with common cancers \nHORIZON-MISS-2027-02-CANCER-03: Phase 1\, including first-in-human clinical trials to test biomarker-guided medicines or multimodal treatment interventions for patients with rare or very rare cancers or cancer subtypes \nHORIZON-MISS-2027-02-CANCER-04: Improving equitable health outcomes and added value for and with cancer patients through health economics research\, health systems research\, and outcomes research \nHORIZON-MISS-2027-02-CANCER-05: Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies\, cancer medical devices\, or cancer medicines \nHORIZON-MISS-2027-02-CANCER-06: Support for a research program on the quality of life (QoL) of young cancer survivors\, led by cancer charities and funding agencies (csa) \nThis is a very interesting topic—a Joint Call for Missions. The call opens on February 4\, 2027\, and closes on September 21\, 2027: \nHORIZON-MISS-2027-06-SOIL-CANCER: Living labs to monitor and mitigate carcinogenic substances in and originating from soils: Evaluating their effects on human cancer risks \n  \n**If you’re interested in any of our job openings or need more information\, please don’t hesitate to contact us. \n\n\n\nRequirements:\nThese calls for proposals are aimed at multidisciplinary European consortia. Unless otherwise specified in the specific conditions of the call\, only legal entities that form a consortium will be eligible to participate in the actions\, provided that the consortium includes\, as beneficiaries\, three legal entities that are independent of one another\, each established in a different country\, in accordance with the following criteria:  \n\n\nat least one independent legal entity established in a Member State; and \n\n\nat least two other independent legal entities\, each established in different Member States or Associated Countries. \n\n\nLegal entities established in Russia\, Belarus\, or in territories of Ukraine not controlled by the government are not eligible. \nHow to apply\nApplications consist of two sections: \n-Part A (to be completed online) contains administrative information related to the consortium\, the budget\, and specific details of the call for proposals. \n-Part B (a template downloaded from the Commission’s website must be completed) contains the scientific and technical aspects of the project. \n  \nSubmission deadline.\nThe 2026 application deadlines are September 15\, and the process is a single-stage process\,   With the exception of call HORIZON-MISS-2026-05-SOIL-02\, which ends on September 23\, 2026. \nThe application deadlines for 2027 are September 21\, 2027\, and the application process consists of a single stage.
URL:https://ibsal.es/en/evento/horizon-europe-cancer-mission-2026-and-2027/
CATEGORIES:Calls for research
END:VEVENT
END:VCALENDAR